Yanoyan, Elsie E.

HRN: 22-49-92  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/24/2026
CEFUROXIME 500MG (TAB)
07/24/2026
07/31/2026
PO
500mg
BID X 7 Days
S/P NSVD; Thinly MSAF
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Reproductive Tract    Compliance to guidelines: